Skip to main content

Main menu

Home
Current Issue
Archive
Info for
Journal Metrics
Other Publications
More
- IIAR
- Conferences
About Us
- General Policy
- Contact

Other Publications

User menu

Register
Subscribe
My alerts
Log in
My Cart

Search

Search for this keyword

Advanced search

Other Publications

Register
Subscribe
My alerts
Log in
My Cart

Search for this keyword

Advanced Search

Home
Current Issue
Archive
Info for
Journal Metrics
Other Publications
More
- IIAR
- Conferences
About Us
- General Policy
- Contact

Visit iiar on Facebook
Follow us on Linkedin

relapsed/refractory multiple myeloma

You have access
Safety and Effectiveness of Ixazomib Dose-escalating Strategy in Ixazomib-Lenalidomide-Dexamethasone Treatment for Relapsed/Refractory Multiple Myeloma
YASUKATA OHASHI, MEGUMI YATABE, DAISUKE NIIJIMA, KENTARO TANI, CHIAKI OGAWA, YUTAKA YACHI, TOSHIYA KAGOO, SAIGEN BOKU, HIRONORI UENO, TAKAHIRO YANO, KOJI HIGAI and AKIHIRO YOKOYAMA

In Vivo September 2020, 34 (5) 2821-2828; DOI: https://doi.org/10.21873/invivo.12108

© 2026 In Vivo